Sabby Management’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$158K Buy
+114,554
New +$224K 0.35% 17
2024
Q2
Sell
-40,300
Closed -$89.1K 55
2024
Q1
$89.1K Sell
40,300
-57,005
-59% -$148K 0.05% 36
2023
Q4
$305K Buy
97,305
+64,600
+198% +$202K 0.3% 18
2023
Q3
$110K Sell
32,705
-85,508
-72% -$350K 0.08% 47
2023
Q2
$459K Buy
118,213
+65,339
+124% +$348K 0.38% 30
2023
Q1
$395K Buy
+52,874
New +$561K 0.34% 26
2022
Q1
Sell
-6,330
Closed -$302K 188
2021
Q4
$263K Buy
+6,330
New +$413K 0.04% 130
2021
Q2
Sell
-1,680
Closed -$183K 184
2021
Q1
$185K Buy
1,680
+867
+107% +$106K 0.04% 136
2020
Q4
$82K Sell
813
-6,072
-88% -$741K 0.02% 96
2020
Q3
$770K Buy
6,885
+5,395
+362% +$729K 0.11% 70
2020
Q2
$224K Buy
+1,490
New +$232K 0.05% 76
2019
Q4
Sell
-1,251
Closed -$234K 86
2019
Q3
$234K Buy
1,251
+750
+150% +$144K 0.13% 65
2019
Q2
$61K Buy
+501
New +$107K 0.08% 75
2019
Q1
Sell
-2,394
Closed -$303K 115
2018
Q4
$303K Sell
2,394
-4,542
-65% -$763K 0.07% 64
2018
Q3
$1.35M Buy
6,936
+3,891
+128% +$978K 0.17% 46
2018
Q2
$1M Sell
3,045
-718
-19% -$392K 0.16% 60
2018
Q1
$3.61M Buy
+3,763
New +$1.69M 0.43% 29

Other funds holding RKDA

Sabby Management's RKDA Position: Q1 2026 in Review

Sabby Management opened a new position in Arcadia Biosciences (RKDA) in Q1 2026: 114,554 shares worth $158K. The stake represents 0.35% of the portfolio and ranks #17 among its holdings. This is a return to the name: Sabby Management previously reported a position in RKDA as recently as Q1 2024.

Sabby Management first reported a position in RKDA in Q1 2018 and has held it in 17 quarters since. The position peaked at $3.61M in Q1 2018. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Sabby Management held 114,554 shares of Arcadia Biosciences worth $158K as of Q1 2026.
  • Arcadia Biosciences was a new Sabby Management position in Q1 2026.
  • Arcadia Biosciences made up 0.35% of Sabby Management's portfolio in Q1 2026, its #17 holding.
  • Sabby Management first reported a position in Arcadia Biosciences in Q1 2018 and has held it in 17 quarters since.
  • Sabby Management's Arcadia Biosciences position peaked at $3.61M in Q1 2018.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Sabby Management's 13F filing for Q1 2026, filed 15 May 2026.